Testing for CYP2C9 before initiating anticoagulant therapy.
Jolobe
Oscar M P
OM
D000925:Anticoagulants / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D013997:Time Factors
D000925:Anticoagulants; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases